Wiser Advisor Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7K Buy
526
+9
+2% +$235 0.01% 161
2026
Q1
$14.5K Buy
517
+8
+2% +$213 0.02% 147
2025
Q4
$12.7K Buy
509
+8
+2% +$202 0.01% 158
2025
Q3
$12.8K Buy
+501
New +$12.4K 0.02% 161
2025
Q2
Sell
-6,360
Closed -$161K 190
2025
Q1
$161K Buy
6,360
+1,522
+31% +$39.8K 0.24% 51
2024
Q4
$128K Buy
4,838
+52
+1% +$1.41K 0.19% 59
2024
Q3
$139K Sell
4,786
-25
-0.5% -$729 0.21% 57
2024
Q2
$135K Sell
4,811
-2,010
-29% -$55.3K 0.21% 55
2024
Q1
$189K Sell
6,821
-13
-0.2% -$361 0.3% 52
2023
Q4
$197K Buy
+6,834
New +$207K 0.33% 50

Other funds holding PFE

Wiser Advisor Group's PFE Position: Q2 2026 in Review

Wiser Advisor Group increased its Pfizer (PFE) stake by 1.7% in Q2 2026, buying an estimated $235 and bringing the position to 526 shares worth $12.7K. The position accounts for 0.01% of the portfolio, ranked #161.

Wiser Advisor Group first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $197K in Q4 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wiser Advisor Group held 526 shares of Pfizer worth $12.7K as of Q2 2026.
  • Wiser Advisor Group bought 9 Pfizer shares in Q2 2026, an estimated $235.
  • Pfizer made up 0.01% of Wiser Advisor Group's portfolio in Q2 2026, its #161 holding.
  • Wiser Advisor Group first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Wiser Advisor Group's Pfizer position peaked at $197K in Q4 2023.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wiser Advisor Group's 13F filing for Q2 2026, filed 17 Aug 2026.